Compounds and methods for inhibiting growth of a protozoan parasite. Methods of treating a protozoan parasite infection in a subject by administering a therapeutically effective amount of a compound as disclosed herein. The compounds and methods can be used to inhibit growth of protozoan parasites such as
Trypanosoma brucei, Trypanosoma cruzi, Leishmania
spp., and
Plasmodium
spp.
and cyclohexane) and the relative rate of O—H insertion into methanol to stereospecific cyclopropanation of the olefin to C—H insertion into cyclohexane are calculated from the ratios of products and substrates. It is found (i) that the reactivities of the substrates decrease in the order of methanol, olefin and cyclohexane and (ii) that electron-donating substituents generally lead to reaction with
Reductive Etherification via Anion-Binding Catalysis
作者:Chenfei Zhao、Christopher A. Sojdak、Wazo Myint、Daniel Seidel
DOI:10.1021/jacs.7b05832
日期:2017.8.2
Reductive condensations of alcohols with aldehydes/ketones to generate ethers are catalyzed by a readily accessible thiourea organocatalyst that operates in combination with HCl. 1,1,3,3-tetramethyldisiloxane serves as a convenient reducing reagent. This strategy is applicable to challenging substrate combinations and exhibits functional group tolerance. Competing reductive homocoupling of the carbonyl
[EN] PYRAZOLE COMPOUNDS AS BTK INHIBITORS<br/>[FR] COMPOSÉS DE PYRAZOLE UTILISÉS EN TANT QU'INHIBITEURS DE BTK
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2015116485A1
公开(公告)日:2015-08-06
The present invention encompasses compounds of the formula (I) wherein the groups R1, Cy, and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
The present invention relates to a novel family of inhibitors of protein kinases. In particular, the present invention relates to inhibitors of the members of the Tec and Src protein kinase families.